Bausch Health Co. Inc. (NYSE: BHC) reported Q4 Adjusted EBITDA of $898 Million. Revenue for the quarter came in at $2.28 billion versus the consensus estimate of $2.2 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2020 revenue of $8.65-8.85 billion, versus the consensus of $8.78 billion. Full-Year Adjusted EBITDA (non-GAAP) in the range of $3.50 - $3.65 billion

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.